Regional brain cytochrome oxidase activity in β-amyloid precursor protein transgenic mice with the Swedish mutation

Neuroscience

Volumn 118, Issue 4, 2003, Pages 1151-1163

  Strazielle, C ^a   Sturchler Pierrat, C ^b   Staufenbiel, M ^a   Lalonde, R ^c,d  

^a UNIVERSITÉ DE LORRAINE   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITÉ DE ROUEN   (France)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alzheimer's disease; Hippocampus; Neuritic plaques; Neuronal metabolism; Quantitative histochemistry

Indexed keywords

AMINO ACID; AMYLOID BETA PROTEIN; CYTOCHROME C OXIDASE; PROTEIN PRECURSOR;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; BRAIN STEM; CELL ACTIVATION; CELL SURVIVAL; CINGULATE GYRUS; CONTROLLED STUDY; DENTATE GYRUS; DYSTROPHY; ENZYME ACTIVITY; FEMALE; FOREBRAIN; GLIA CELL; HIPPOCAMPUS; LIMBIC CORTEX; LOCUS CERULEUS; MEDIAN RAPHE NUCLEUS; METABOLIC DISORDER; MITOCHONDRION; MOUSE; MUTATION; NEOCORTEX; NEOSTRIATUM; NERVE CELL; NEURITE; NONHUMAN; OLFACTORY SYSTEM; OXIDATIVE STRESS; PARABRACHIAL NUCLEUS; PERIAQUEDUCTAL GRAY MATTER; PONS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RED NUCLEUS; SENILE PLAQUE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SUPERIOR COLLICULUS; THALAMUS PARAFASCICULAR NUCLEUS; TRANSGENIC MOUSE; TRIGEMINAL NUCLEUS; VISUAL CORTEX;

EID: 0037728863     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00037-X     Document Type: Article

References (74)

1. Amaral D.G., Witter M.P. Hippocampal formation. Paxinos G. The rat nervous system. 2nd ed: 1995;443-486 Academic Press, New York.
2. Beitz A.J. Periaqueductal gray. Paxinos G. The rat nervous system. 2nd ed: 1995;173-182 Academic Press, New York.
3. Bondolfi L., Calhoun M., Ermini F., Kuhn H.G., Wiederhold K.H., Walker L., Staufenbiel M., Jucker M. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci. 22:2002;515-522.
4. Borchelt D.R. Inherited neurodegenerative diseases and transgenic models. Lab Anim Sci. 48:1998;604-610.
5. Calhoun M.E., Wiederhold K.-H., Abramowski D., Phinney A.L., Probst A., Sturchler-Pierrat C., Staufenbiel M., Sommer B., Jucker M. Neuron loss in APP transgenic mice. Nature. 395:1998;755-756.
6. Chagnon P., Bétard C., Robitaille Y., Cholette A., Gauvreau D. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport. 6:1995;711-715.
7. Casley C.S., Canevari L., Land J.M., Clark J.B., Sharpe M.A. β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem. 80:2002;91-100.
8. Cassarino D.S., Bennett J.P. An evaluation of the role of mitochondria in neurodegenerative diseases mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration . Brain Res Rev. 29:1999;1-25.
9. Cottrell D.A., Blakely E.L., Johnson M.A., Ince P.G., Turnbull D.M. Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology. 57:2001;260-264.
10. Czech C., Tremp G., Pradier L. Presenilins and Alzheimer's disease biological functions and pathogenic mechanisms . Prog Neurobiol. 60:2000;363-384.
11. de la Torre J.C. Critically attained threshold of cerebral hypoperfusion the CATCH hypothesis of Alzheimer's disease . Neurobiol Aging. 21:2000;331-342.
12. De Santi S., de Leon M.J., Rusinek H., Convit A., Tarshish C.Y., Roche A., Tsui W.H., Kandil E., Boppana M., Daisley K., Wang G.J., Schlyer D., Fowler J. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging. 22:2001;529-539.
13. Dickson D.W. Microglia in Alzheimer's disease and transgenic models how close the fit? Am J Pathol. 154:1999;1627-1631.
14. Divac I., Kosman A., Björklund A., Lindvall O. Subcortical projections to the prefrontal cortex of the rat as revealed by the horseradish peroxidase technique. Neuroscience. 3:1978;785-796.
15. Dodart J.-C., Matthis C., Bales K.R., Paul S.M., Ungerer A. Early regional glucose hypometabolism in transgenic mice overexpressing the V717F β-amyloid precursor protein. Neurosci Lett. 277:1999;49-52.
16. Duff K. Transgenic mouse models of Alzheimer's disease. Crusio W., Gerlai R. Handbook of molecular-genetic techniques for brain and behavior research: techniques in the behavioral and neural sciences. 1999;880-894 Elsevier, Amsterdam. 13.
17. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates. 1997;Academic Press, New York.
18. Games D., Adams D., Alessandri R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
19. Gonzalez-Lima F., Berndt J.D., Valla J.E., Games D., Reiman E.M. Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. Neuroreport. 12:2001;2375-2379.
20. Gonzalez-Lima F., Jones D. Quantitative mapping of cytochrome oxidase activity in the central auditory system of the gerbil a study with calibrated activity standards and metal-intensified histochemistry . Brain Res. 660:1994;34-39.
21. Hevner R.F., Wong-Riley M.T.T. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J Neurosci. 13:1993;1805-1819.
22. Hess H.H., Pope A. Ultramicrospectrophotometric determination of cytochrome oxidase for quantitative histochemistry. J Biol Chem. 204:1953;295-306.
23. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnoson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L.R., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 21:2001;3017-3023.
24. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
25. Hsiao K.K., Borchelt D.R., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S., Price D., Iadecola C., Clark H.B., Carlson G. Age-related CNS disorder and early death in transgenic FVB-N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218.
26. Iadecola C., Zhang F., Niwa K., Eckman C., Turner S.K., Fischer E., Younkin S., Borchelt D.R., Hsiao K.K., Carlson G.A. SODI rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nature Neurosci. 2:1999;157-161.
27. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology. 50:1998;1585-1593.
28. Sw transgenic mice develop age-related Aβ deposits and neuropil abnormalities but no neuronal loss in CA1. J Neuropathol Exp Neurol. 56:1997;965-973.
29. Iverfeldt K., Walaas S.I., Greengard P. Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc Natl Acad Sci USA. 90:1993;4146-4150.
30. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals evidence that an initially deposited species is Aβ42(43) . Neuron. 13:1994;45-53.
31. Jack C.R., Petersen R.C., Xu Y., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 51:1998;993-999.
32. Johnson K.A., Albert M. Perfusion in prodromal AD. Neurobiol Aging. 21:2000;289-292.
33. Kalaria R.N., Harshbarger-Kelly M., Cohen D.L., Premkumar D.R.D. Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiol Aging. 17:1996;687-693.
34. Kish S.J., Bergeron C., Rajput A., Doxic S., Mastrogiacomo F., Chang L.-J., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J Neurochem. 59:1992;776-779.
35. Kish S.J., Mastrogiacomo F., Gutman M., Furukawa Y., Taanman J.-W., Dozic S., Pandolfo M., Lamarche J., DiStefano L., Chang L.-J. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders a nonspecific change? J Neurochem. 72:1999;700-707.
36. Kovacs T., Cairns N.J., Lantos P.L. Beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. J Neuropathol Appl Neurobiol. 25:1999;481-491.
37. Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C. (2002) Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res 956:36-44.
38. Lee J.-Y., Mook-Jung I., Koh J.-Y. Histochemically reactive zinc in plaques of the Swedish mutant β-amyloid precursor protein transgenic mice. J Neurosci. 19:(RC10):1999;1-5.
39. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J Neurosci. 16:1996;5795-5811.
40. Maurer I., Zierz S., Möller H.-J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging. 21:2000;455-462.
41. Moechars D., Dewachter I., Lorent K., Reversé D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Van Den Haute C., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem. 274:1999;6483-6492.
42. Nagy Z., Esiri M.M., LeGris M., Matthews P.M. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol. 97:1999;346-354.
43. 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects . J Neurol Neurosurg Psychiatry. 54:2001;672-678.
44. Paris D., Town T., Mori T., Parker T.A., Humphrey J., Mullan M. Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway. Neurobiol Aging. 21:2000;183-197.
45. Parker W.D., Davis R.E. Primary mitochondrial DNA defects as a causative event in Alzheimer's disease. Beal M.F., Howell N., Bodis-Wollner I. Mitochondria and free radicals in neurodegenerative diseases. 1997;319-333 Wiley-Liss, New York.
46. Parker W.D., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology. 40:1990;1302-1303.
47. Parker W.D., Parks J. Cytochrome c oxidase in Alzheimer's disease brain purification and characterization . Neurology. 45:1995;482-486.
48. Parker W.D., Parks J., Filley C.M., Kleinschmidt-DeMasters B.K. Electron transport chain defects in Alzheimer's disease brain. Neurology. 44:1994;1090-1096.
49. Parks J.K., Smith T.S., Trimmer P.A., Bennett J.P., Parker W.D. Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem. 76:2001;1050-1056.
50. Parvizi J., Van Hoesen G.W., Damasio A. Selective pathological changes of the periaqueductal gray matter in Alzheimer's disease. Ann Neurol. 48:2000;344-353.
51. Phinney A.L., Deller T., Stalder M., Calhoun M.E., Frotscher M., Sommer B., Staufenbiel M., Jucker M. Cerebral amyloid induced aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci. 19:1999;8552-8559.
52. Pietrini P., Alexander G.E., Furey M.L., Hampel H., Guazzelli M. The neurometabolic landscape of cognitive decline in vivo studies with positron emission tomography in Alzheimer's disease . Int J Psychophysiol. 37:2000;87-98.
53. Rapoport S.I. Functional brain imaging in the resting state and during activation in Alzheimer's disease implications for disease mechanisms involving oxidative phosphorylation . Ann NY Acad Sci. 893:1999;138-153.
54. Richards S.-J., Dunnett S.B. Genetic models of Alzheimer's disease and their psychopathological validity. Alzheimer Rep. 2:1999;199-208.
55. Rombouts S.A.R.B., Barkhof F., Witter M.P., Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett. 285:2000;231-233.
56. Rüb U., Del Tredici K., Schultz C., Thal D.R., Braak E., Braak H. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol. 101:2001;555-564.
57. Seabrook G.R., Rosahl T.W. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology. 38:1999;1-17.
58. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-A31.
59. Sirinathsinghji D.J.S. Transgenic mouse models of Alzheimer's disease. Biochem Soc Trans. 26:1998;504-508.
60. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L.R., Siedlak S.L., Tabaton M., Perry G. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem. 70:1998;2212-2215.
61. Stalder M., Phinney A., Probst A., Sommer B., Staufenbiel M., Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol. 154:1999;1673-1684.
62. Strazielle C., Krémarik P., Ghersi-Egea J.-F., Lalonde R. Regional brain variations of cytochrome oxidase activity and motor coordination in Lurcher mutant mice. Exp Brain Res. 121:1998;35-45.
63. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mislt C., Rothacher S., Ledermann B., Bürki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA. 94:1997;13287-13292.
64. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P., Davis R.E., Parker W.D. Cybrids in Alzheimer's disease a cellular model of disease? Neurology. 49:1997;918-925.
65. Ter Laak H.J., Renkawek K., van Workum F.P. The olfactory bulb in Alzheimer disease a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction . Alzheimer Dis Assoc Disord. 8:1994;38-48.
66. Terry R.D., Katzman R. Senile dementia of the Alzheimer type. Ann Neurol. 14:1983;497-506.
67. Valla J., Berndt J.D., Gonzalez-Lima F. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients superficial laminar cytochrome oxidase associated with disease duration . J Neurosci. 21:2001;4923-4930.
68. van Leuven F. Single and multiple transgenic mice as models for Alzheimer's disease. Prog Neurobiol. 61:2000;305-312.
69. Vickers J.C., Dickson T.C., Adlard P.A., Saunders H.L., King C.E., McCormack G. The cause of neuronal degeneration in Alzheimer's disease. Prog Neurobiol. 60:2000;139-165.
70. Vogt B.A., Miller M.W. Cortical connections between rat cingulate cortex and visual, motor, and postsubicular cortices. J Comp Neurol. 216:1983;192-210.
71. Winkler D.T., Bondolfi L., Herzig M.C., Jann L., Calhoun M.E., Wiederhold K.-H., Tolnay M., Staufenbiel M., Jucker M. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci. 21:2001;1619-1627.
72. Wong-Riley M.T.T. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171:1979;11-28.
73. Wong-Riley M.T.T. Cytochrome oxidase an endogenous metabolic marker for neuronal activity . Trends Neurosci. 12:1989;94-101.
74. Zhang C., Wong-Riley M.T.T. Expression and regulation of NMDA receptor subunit R1 and neuronal nitric oxide synthase in cortical neuronal cultures correlation with cytochrome oxidase . J Neurocytol. 28:1999;525-539.